EUVIMEDEUVIMED entdecken
Crossref

A comprehensive study of Chuanwang Xiaoyan capsule based on characterization of chemical constituents in vitro and in vivo using ultra‐high‐performance liquid chromatography‐quadrupole‐Exactive Orbitrap mass spectrometry and pharmacokinetic study of multiple components in rats using ultra‐high‐performance liquid chromatography‐triple quadrupole‐tandem mass spectrometry

Yufeng Wang, Hongjin Wang, Aichun Gao, Lan Wei, Jia Yu iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Yufeng Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Tandem Mass Spectrometry, Rats, Sprague-Dawley. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chuanwang Xiaoyan (CWXY) capsule is primarily used to treat a variety of acute and chronic inflammations, including acute and chronic pharyngitis and tonsillitis. However, a systematic study of its chemical constituents is still not available. This study evaluated the chemical constituents in vitro and metabolite profiles in vivo of CWXY using ultra‐high‐performance liquid chromatography (UHPLC) coupled with Q‐Exactive Orbitrap mass spectrometry, and the pharmacokinetic behaviors of the nine main components in rats were detected using ultra‐high‐performance liquid chromatography‐triple quadrupole‐mass spectrometry (UPLC‐QQQ‐MS/MS). A total of 92 chemical constituents in CWXY were preliminarily identified in vitro. After oral administration to rats, 56 prototype components and 128 metabolites of CWXY were detected in the biological samples of rat plasma, urine, bile, and feces. Of these prototype components and metabolites, seven new compounds, namely M15, M16, M25, M30, M31, M71, and M128, were detected for the first time. The quantitation method of nine components in rat plasma was developed using a pharmacokinetic study. To the best of our knowledge, this study was the first to investigate the pharmacokinetic behavior of triumbelletin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalTandem Mass SpectrometryRats, Sprague-DawleyAnimalsChromatography, High Pressure LiquidRatsMaleReproducibility of ResultsLinear ModelsLimit of Detection

Stichwörter der Autor:innen

Chuanwang Xiaoyan capsuleUHPLC‐Q‐Exactive Orbitrap MSchemical constituentsmetabolite profilespharmacokinetics

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.

ORCID-Profile: Jia Yu

Zitieren

APA

Wang, Y., Wang, H., Gao, A., Wei, L., & Yu, J. (2024). A comprehensive study of Chuanwang Xiaoyan capsule based on characterization of chemical constituents in vitro and in vivo using ultra‐high‐performance liquid chromatography‐quadrupole‐Exactive Orbitrap mass spectrometry and pharmacokinetic study of multiple components in rats using ultra‐high‐performance liquid chromatography‐triple quadrupole‐tandem mass spectrometry. Biomedical Chromatography. https://doi.org/10.1002/bmc.5930

Vancouver

Wang Y, Wang H, Gao A, Wei L, Yu J. A comprehensive study of Chuanwang Xiaoyan capsule based on characterization of chemical constituents in vitro and in vivo using ultra‐high‐performance liquid chromatography‐quadrupole‐Exactive Orbitrap mass spectrometry and pharmacokinetic study of multiple components in rats using ultra‐high‐performance liquid chromatography‐triple quadrupole‐tandem mass spectrometry. Biomedical Chromatography. 2024. doi:10.1002/bmc.5930

BibTeX
@article{Wang2024,
  author = {Wang, Yufeng and Wang, Hongjin and Gao, Aichun and Wei, Lan and Yu, Jia},
  title = {A comprehensive study of Chuanwang Xiaoyan capsule based on characterization of chemical constituents in vitro and in vivo using ultra‐high‐performance liquid chromatography‐quadrupole‐Exactive Orbitrap mass spectrometry and pharmacokinetic study of multiple components in rats using ultra‐high‐performance liquid chromatography‐triple quadrupole‐tandem mass spectrometry},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5930}
}
Kostenlos starten →